109 related articles for article (PubMed ID: 17286961)
1. Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division.
Nakanishi A; Han X; Saito H; Taguchi K; Ohta Y; Imajoh-Ohmi S; Miki Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):34-40. PubMed ID: 17286961
[TBL] [Abstract][Full Text] [Related]
2. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.
Daniels MJ; Wang Y; Lee M; Venkitaraman AR
Science; 2004 Oct; 306(5697):876-9. PubMed ID: 15375219
[TBL] [Abstract][Full Text] [Related]
3. Mortalin controls centrosome duplication via modulating centrosomal localization of p53.
Ma Z; Izumi H; Kanai M; Kabuyama Y; Ahn NG; Fukasawa K
Oncogene; 2006 Aug; 25(39):5377-90. PubMed ID: 16619038
[TBL] [Abstract][Full Text] [Related]
4. A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2.
Han X; Saito H; Miki Y; Nakanishi A
Oncogene; 2008 May; 27(21):2969-77. PubMed ID: 18059333
[TBL] [Abstract][Full Text] [Related]
5. The helix-loop-helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers.
Hasskarl J; Duensing S; Manuel E; Münger K
Oncogene; 2004 Mar; 23(10):1930-8. PubMed ID: 14755252
[TBL] [Abstract][Full Text] [Related]
6. BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.
Malik S; Saito H; Takaoka M; Miki Y; Nakanishi A
Cell Cycle; 2016 Aug; 15(16):2145-2156. PubMed ID: 27433848
[TBL] [Abstract][Full Text] [Related]
7. GFP-centrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7.
D'Assoro AB; Stivala F; Barrett S; Ferrigno G; Salisbury JL
Ital J Anat Embryol; 2001; 106(2 Suppl 1):103-10. PubMed ID: 11729945
[TBL] [Abstract][Full Text] [Related]
8. Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP).
Wali N; Hosokawa K; Malik S; Saito H; Miyaguchi K; Imajoh-Ohmi S; Miki Y; Nakanishi A
Biochem Biophys Res Commun; 2014 Jan; 443(4):1148-54. PubMed ID: 24384087
[TBL] [Abstract][Full Text] [Related]
9. Cyclin E-dependent localization of MCM5 regulates centrosome duplication.
Ferguson RL; Maller JL
J Cell Sci; 2008 Oct; 121(Pt 19):3224-32. PubMed ID: 18799789
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle.
Ko MJ; Murata K; Hwang DS; Parvin JD
Oncogene; 2006 Jan; 25(2):298-303. PubMed ID: 16170356
[TBL] [Abstract][Full Text] [Related]
11. Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative cases.
Syamala V; Syamala VS; Sreeja L; Raveendran PB; Vijayalekshmi RV; Sheeja VR; Santhi S; Kuttan R; Abraham EK; Ankathil R
J Exp Ther Oncol; 2008; 7(3):227-36. PubMed ID: 19066131
[TBL] [Abstract][Full Text] [Related]
12. Centrosome function in normal and tumor cells.
Sankaran S; Parvin JD
J Cell Biochem; 2006 Dec; 99(5):1240-50. PubMed ID: 16817224
[TBL] [Abstract][Full Text] [Related]
13. BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.
Wang HF; Takenaka K; Nakanishi A; Miki Y
Cancer Res; 2011 Jan; 71(1):68-77. PubMed ID: 21084279
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication.
Ugrinova I; Monier K; Ivaldi C; Thiry M; Storck S; Mongelard F; Bouvet P
BMC Mol Biol; 2007 Aug; 8():66. PubMed ID: 17692122
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.
Misra S; Sharma S; Agarwal A; Khedkar SV; Tripathi MK; Mittal MK; Chaudhuri G
Mol Cancer; 2010 Mar; 9():50. PubMed ID: 20202217
[TBL] [Abstract][Full Text] [Related]
16. Human NEIL1 localizes with the centrosomes and condensed chromosomes during mitosis.
Hildrestrand GA; Rolseth V; Bjørås M; Luna L
DNA Repair (Amst); 2007 Oct; 6(10):1425-33. PubMed ID: 17556049
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
18. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
19. WTIP interacts with BRCA2 and is essential for BRCA2 centrosome localization in cervical cancer cell.
Zhang J; Xu J; Wang G; Sun P; Yan T; Zhao X
Arch Gynecol Obstet; 2016 Nov; 294(6):1311-1316. PubMed ID: 27535760
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of BRCA2 gene mutations among familial and/or early-onset breast cancer patients in eastern Shandong of China].
Ma ZL; Cao MZ; Li WF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):195-8. PubMed ID: 18393245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
